5-substituted 2-aryl-4-pyrimidinones

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S314000, C544S319000

Reexamination Certificate

active

11147895

ABSTRACT:
Arylpyrimidinone compounds that act as selective modulators of CRF 1 receptors are provided. These compounds are useful in the treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided.Compounds of the invention are also useful as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding. Methods of using the compounds in receptor localization studies are given.

REFERENCES:
patent: 4665175 (1987-05-01), Maurer
patent: 4686290 (1987-08-01), Maurer
patent: 5254558 (1993-10-01), Bernstein et al.
patent: 5670494 (1997-09-01), Dolle et al.
patent: 5861380 (1999-01-01), Gyorkos et al.
patent: 5948785 (1999-09-01), Akahoshi et al.
patent: 5972946 (1999-10-01), Murata et al.
patent: 6001814 (1999-12-01), Gyorkos et al.
patent: 6121202 (2000-09-01), Karp et al.
patent: 6943173 (2005-09-01), Hodgetts et al.
patent: 2002/0058667 (2002-05-01), Castelhano et al.
patent: 1122533 (1962-01-01), None
patent: 0 826 671 (1998-03-01), None
patent: 0 826 673 (1998-03-01), None
patent: 0 936 216 (1999-08-01), None
patent: 0 940 400 (1999-09-01), None
patent: WO-93/21210 (1993-10-01), None
patent: WO-93/21214 (1993-10-01), None
patent: WO-95/26958 (1995-10-01), None
patent: WO-96/39400 (1996-12-01), None
patent: WO-97/14684 (1997-04-01), None
patent: WO-99/32459 (1999-07-01), None
patent: WO-99/36426 (1999-07-01), None
patent: WO-99/62518 (1999-12-01), None
patent: WO-99/62538 (1999-12-01), None
Hullar T. L. et al., “Pyridoxal Phosphate. III. Pyrimidine Analogs . . . ” J. Med. Chem., vol. 12, No. 3, pp. 424-426 (1969).
Dolle et al., “First Examples of Peptidomimetic Inhibitors of Inteleukin-1 Converting Enzyme”, J. Med. Chem., vol. 39, pp. 2438-2440, (1996).
Veale et al., “Nonpeptidic Inhibitors of Human Leukocyte Elastase . . . ”, J. Med. Chem., vol. 38, pp. 98-108, (1995).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5-substituted 2-aryl-4-pyrimidinones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-substituted 2-aryl-4-pyrimidinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-substituted 2-aryl-4-pyrimidinones will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3723826

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.